Mark N. Milton
Nessuna posizione attualmente
Profilo
Mark N.
Milton is Vice President of Nonclinical Development for Tempo Pharmaceuticals, Inc. He was Senior Director of Drug Metabolism and Pharmacokinetics for Millennium Pharmaceuticals and an Associate Director of ICG (UK) Ltd.
(trade name Searle) and Pharmacia, Inc. Dr. Milton holds a PhD degree.
Precedenti posizioni note di Mark N. Milton
| Società | Posizione | Fine |
|---|---|---|
ICG (UK) Ltd.
 ICG (UK) Ltd. Industrial MachineryProducer Manufacturing Part of GEA Group AG, ICG (UK) Ltd. is a manufacturer of evaporators and condensers for the industrial refrigeration markets. The company is based in Fareham, UK. ICG (UK was acquired by GEA Group AG on August 27, 2008. | Corporate Officer/Principal | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
| Pharmacia, Inc. | Corporate Officer/Principal | - |
Cerulean Pharma, Inc.
 Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 4 |
|---|---|
Cerulean Pharma, Inc.
Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
| Pharmacia, Inc. | |
ICG (UK) Ltd.
ICG (UK) Ltd. Industrial MachineryProducer Manufacturing Part of GEA Group AG, ICG (UK) Ltd. is a manufacturer of evaporators and condensers for the industrial refrigeration markets. The company is based in Fareham, UK. ICG (UK was acquired by GEA Group AG on August 27, 2008. | Producer Manufacturing |
- Borsa valori
- Insiders
- Mark N. Milton
